PCM
ANAC

Price Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Price Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,787
Closed -$740K – 303
2015
Q1 		$740K Buy
+12,787
New +$543K 0.46% 26

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Price Capital Management's ANAC Position: Q2 2015 in Review

Price Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2015, closing a stake of 12,787 shares — an estimated $740K sold.

Price Capital Management first reported a position in ANAC in Q1 2015 and held it in 1 quarter. The position peaked at $740K in Q1 2015. 177 funds tracked by Wall St. Rank hold ANAC as of Q2 2015.

  • Price Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2015 after selling out during the quarter.
  • Price Capital Management sold 12,787 ANACOR PHARMACEUTICALS INC COM shares in Q2 2015, an estimated $740K.
  • Price Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 1 quarter.
  • Price Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $740K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.